These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19804470)

  • 1. Less protease-resistant PrP in a patient with sporadic CJD treated with intraventricular pentosan polysulphate.
    Terada T; Tsuboi Y; Obi T; Doh-ura K; Murayama S; Kitamoto T; Yamada T; Mizoguchi K
    Acta Neurol Scand; 2010 Feb; 121(2):127-30. PubMed ID: 19804470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion.
    Honda H; Sasaki K; Minaki H; Masui K; Suzuki SO; Doh-Ura K; Iwaki T
    Neuropathology; 2012 Apr; 32(2):124-32. PubMed ID: 21801238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease.
    Todd NV; Morrow J; Doh-ura K; Dealler S; O'Hare S; Farling P; Duddy M; Rainov NG
    J Infect; 2005 Jun; 50(5):394-6. PubMed ID: 15907546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate.
    Parry A; Baker I; Stacey R; Wimalaratna S
    J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):733-4. PubMed ID: 17314188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob disease.
    Whittle IR; Knight RS; Will RG
    Acta Neurochir (Wien); 2006 Jun; 148(6):677-9; discussion 679. PubMed ID: 16598408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.
    Newman PK; Todd NV; Scoones D; Mead S; Knight RS; Will RG; Ironside JW
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):921-4. PubMed ID: 24554103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered properties of amyloidogenic prion protein in genetic Creutzfeldt-Jakob disease with PRNP V180I mutation in response to pentosan polysulfate.
    Shijo M; Yoshimura M; Omae T; Hashimoto G; Mizoguchi T; Kuwashiro T; Komori T; Tsuboi Y; Saito T; Nakagawa M; Itoh K; Honda H
    Brain Pathol; 2023 Sep; 33(5):e13197. PubMed ID: 37525413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases.
    Tsuboi Y; Doh-Ura K; Yamada T
    Neuropathology; 2009 Oct; 29(5):632-6. PubMed ID: 19788637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate?
    Rainov NG; Tsuboi Y; Krolak-Salmon P; Vighetto A; Doh-Ura K
    Expert Opin Biol Ther; 2007 May; 7(5):713-26. PubMed ID: 17477808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental treatment may show promise for vCJD.
    Pincock S
    Lancet; 2003 Oct; 362(9390):1130. PubMed ID: 14558510
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK.
    Bone I; Belton L; Walker AS; Darbyshire J
    Eur J Neurol; 2008 May; 15(5):458-64. PubMed ID: 18355301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New knowledge about Creutzfeldt-Jakob disease can yield therapeutic possibilities].
    Stølsmark T; Tysnes OB
    Tidsskr Nor Laegeforen; 2010 Mar; 130(6):601-4. PubMed ID: 20349004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein oligomers in Creutzfeldt-Jakob disease detected by gel-filtration centrifuge columns.
    Minaki H; Sasaki K; Honda H; Iwaki T
    Neuropathology; 2009 Oct; 29(5):536-42. PubMed ID: 19389076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models.
    Doh-ura K; Ishikawa K; Murakami-Kubo I; Sasaki K; Mohri S; Race R; Iwaki T
    J Virol; 2004 May; 78(10):4999-5006. PubMed ID: 15113880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
    Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creutzfeldt-Jakob disease prion proteins in human brains.
    Bockman JM; Kingsbury DT; McKinley MP; Bendheim PE; Prusiner SB
    N Engl J Med; 1985 Jan; 312(2):73-8. PubMed ID: 3917302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002.
    Head MW; Bunn TJ; Bishop MT; McLoughlin V; Lowrie S; McKimmie CS; Williams MC; McCardle L; MacKenzie J; Knight R; Will RG; Ironside JW
    Ann Neurol; 2004 Jun; 55(6):851-9. PubMed ID: 15174020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A traceback phenomenon can reveal the origin of prion infection.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.
    Parchi P; Castellani R; Capellari S; Ghetti B; Young K; Chen SG; Farlow M; Dickson DW; Sima AA; Trojanowski JQ; Petersen RB; Gambetti P
    Ann Neurol; 1996 Jun; 39(6):767-78. PubMed ID: 8651649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creutzfeldt-Jakob disease associated with a V203I homozygous mutation in the prion protein gene.
    Komatsu J; Sakai K; Hamaguchi T; Sugiyama Y; Iwasa K; Yamada M
    Prion; 2014; 8(5):336-8. PubMed ID: 25495585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.